2013 Joint Summits Lunch and Learns

Tuesday, March 19

12:15 p.m. – 1:15 p.m. | Room: Cyril Magnin III

Sponsored by Oracle Health Sciences

Translational Research Center: A Data Management Platform to Support Value Based, Personalized Medicine

This presentation will focus on the new analytics solutions that will be required to provide a scalable, secure platform for personalized medicine that accelerates biomarker discovery, validation and ultimately decision making at the point of care. This session will also discuss the challenges associated with integrating cross platform ‘omics’ data in a manner that scales to thousands of whole genome sequences whilst integrating with longitudinal clinical data from EMRs, case reports, registries and other “real world”  data sources to provide an integrated view across genotype and phenotype. Specifically, Oracle will demonstrate its Translational Research Center (TRC) platform that is being implemented by many of the world’s leading academic medical centers, integrated delivery networks and cancer centers to answer the “hard questions” in healthcare – what works, for whom, why, in what context and at what cost?

Wednesday, March 20

12:15 p.m. – 1:15 p.m.

Sponsored by Velos

Clinical Research Tools: Experience with Velos Volunteer Management: Benefits Realized in Year One and Plans for the Future

Presenter: Julie Eckstrand, Assistant Director, Clinical Support Services and Quality Management, Duke Clinical Research Unit

Presenter Bio: Julie currently serves as the Assistant Director of Clinical Support Services and Quality Management for the DCRU and has been with the unit since Nov 2009. Her areas of responsibility include Investigational Drug Services, Information Technology Solutions, Nutrition Services, Laboratory Services, SOP’s/Quality Management and facilities.

She served as a Clinical Pharmacist on the Health Analytics and Patient Safety Initiatives team for Duke University Health System (DUHS) after coming to Duke University Hospital (DUH) in 2006. Prior to that she spent 8 years as a Sr. Clinical Supplies Project Manager for a cGMP contract packaging company, 3 years as a Clinical Pharmacist in Bone Marrow and Stem Cell Transplant at Roswell Park Cancer Institute, and 8 years as the Manager of Quality Improvement/Investigational Drug Services/ Drug Use Evaluation and ACTG Pharmacist at the Erie County Medical Center in Buffalo, New York.

She graduated from Ohio Northern University in 1987 with a BS in Pharmacy, and completed ASHP General Hospital Pharmacy Residency at the Erie County Medical Center- Buffalo, New York in 1988. She conducted graduate work in Drug Literature Evaluation at the SUNY Buffalo School of Pharmacy where she was also a Clinical Instructor in Pharmacy Practice.

Thusday, March 21

12:15 p.m. – 1:15 p.m. | Room: Cyril Magnin III 

Sponsored by Recombinant by Deloitte

Michael Kahn, MD, PhD, Associate Professor, Department of Pediatrics, University of Colorado, and Director of Clinical Informatics in the Department of Quality & Patient Safety at The Children’s Hospital, Denver.

Dr. Kahn will be speaking on his choice of OMOP, the Observational Medical Outcomes Partnership, for the data model and tools used to implement the open source ROSITA server for the SAFTINet project, and the role that Recombinant by Deloitte has played in implementing ROSITA.

Lisa M. Schilling, MD, MSPH, Associate Professor of Medicine, Division of General Internal Medicine, University of Colorado Health Sciences Center; Director, Evidence-based Medicine and Medical Informatics Curriculum, School of Medicine; and Director, Scalable Architecture for Federated Therapeutic Inquiries Network (SAFTINet).

Dr. Schilling is the Principle Investigator, SAFTINet, the AHRQ funded effort that is using the OMOP software.